Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: A general review of metal mixture mechanism in brain

Environmental Toxicology and Pharmacology

Volumn 48, Issue , 2016, Pages 203-213

  Karri, Venkatanaidu ^a   Schuhmacher, Marta ^a   Kumar, Vikas ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Cognitive dysfunction; Hippocampus; Metal mixture; Metal toxicity; Mode of actions

Indexed keywords

ARSENIC; CADMIUM; LEAD; METHYLMERCURY; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; DRUG MIXTURE; GLUTAMIC ACID; HEAVY METAL; METHYLMERCURY DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLLUTANT; PROTEIN BINDING;

BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CHEMICAL INTERACTION; COGNITIVE DEFECT; DISEASE PREDISPOSITION; DOWN REGULATION; EXPOSURE; HIPPOCAMPUS; HUMAN; NEUROTOXICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; ANIMAL; BINDING COMPETITION; BIOLOGICAL MODEL; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG MIXTURE; HEAVY METAL POISONING, NERVOUS SYSTEM; METABOLISM; PHARMACOKINETICS; POLLUTANT; TOXICITY;

ANIMALS; ARSENIC; BINDING, COMPETITIVE; CADMIUM; CALCIUM; COGNITIVE DYSFUNCTION; COMPLEX MIXTURES; ENVIRONMENTAL POLLUTANTS; GLUTAMIC ACID; HEAVY METAL POISONING, NERVOUS SYSTEM; HIPPOCAMPUS; HUMANS; LEAD; METALS, HEAVY; METHYLMERCURY COMPOUNDS; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, N-METHYL-D-ASPARTATE; RISK FACTORS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84995549298     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2016.09.016     Document Type: Review

References (151)

1. Ahmed, S., Mahabbate Khoda, S., Rekha, R.S., Gardner, R.M., Ameer, S.S., Moore, S., Ekstrom, E.C., Vahter, M., Raqib, R., Arsenic associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ. Health Perspect. 119:2 (2011), 258–264.
2. Ali, S.F., LeBel, C.P., Bondy, S.C., Reactive oxygen species formation as a biomarker of methyl mercury and trimethyltin neurotoxicity. Neurotoxicology 13:3 (1992), 637–648.
3. Alshuaib, W.B., Byerly, L., Modulation of membrane currents by cyclic AMP in cleavage arrested drosophila neurons. J. Exp. Biol. 199:3 (1996), 537–548.
4. Alves, R.I.S., Sampaio, C.F., Nadal, M., Schuhmacher, M., Domingo, J.L., Segura-Munoz, S.I., Metal concentrations in surface water and sediments from pardo river, brazil: Human health risks. Environ. Res. 133 (2014), 149–155.
5. Angelica, M.D., Fong, Y., Environmental toxicity and poor cognitive outcomes in children and adults. J. Environ. Health 76:6 (2014), 130–138.
6. Ankley, G.T., Bennett, R.S., Erickson, R.J., Hoff, D.J., Hornung, M.W., Johnson, R.D., Mount, D.R., Nichols, J.W., Russom, C.L., Schmieder, P.K., Serrrano, J.A., Tietge, J.E., Villeneuve, D.L., Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 29:3 (2010), 730–741.
7. Antonio, M.T., Corredor, L., Leret, M.L., Study of the activity of several brain enzymes like markers of the neurotoxicity induced by perinatal exposure to lead and/or cadmium. Toxicol. Lett. 143:3 (2003), 331–340.
8. Aschner, M., Aschner, J.L., Mercury neurotoxicity: mechanisms of blood brain barrier transport. Neurosci. Biobehav. Rev. 14:108 (1990), 169–176.
9. Aschner, M., et al. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 221 (2007), 131–147.
10. Ashauer, R., Agatz, A., Albert, C., Ducrot, V., Galic, N., Hendriks, J., Jager, T., Kretschmann, A., O'Connor, I., Rubach, M.N., Nyman, A.M., Schmitt, W., Stadnicka, J., van den Brink, P.J., Preuss, T.G., Toxicokinetic-toxicodynamic modeling of quantal and graded sublethal endpoints: a brief discussion of concepts. Environ. Toxicol. Chem. 30:11 (2011), 2519–2524.
11. Ashok, A., Rai, N.K., Tripathi, S., Bandyopadhyay, S., Exposure to As, Cd, and Pb mixture induces amyloidogenic APP processing and cognitive impairments via oxidative Stress dependent neuroinflammation in young rats. Toxicol. Sci. 143:1 (2015), 64–80.
12. Atchison, D., Hare, F., Mechansims of methyl mercury induced neurotoxicity, vol.8, 1994, 622–629 Available online: http://www.fasebj.org/.
13. Atwood C.S., Moir R.D., Scarpa R.C., Michael N.E., Romano D.M., Mariana A., Tanzi R.E., Ashley I., Huang X., Bacarra N.M.E., Hartshorn M. A., Bush A.I., 1998. Dramatic aggregation of alzheimer A(by Cu (II) is induced by conditions representing physiological acidosis 273(21), 12817–12826.
14. Baranowska-Bosiacka, I., Gutowska, I., Rybicka, M., Nowacki, P., Chlubek, D., Neurotoxicity of lead. hypothetical molecular mechanisms of synaptic function disorders. Neurol. Neurochir. Pol. 46:6 (2012), 569–578.
15. Basha, M.R., Wei, W., Bakheet, S.A., Benitez, N., Siddiqi, H.K., Ge, Y.W., Lahiri, D.K., Zawia, N.H., The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 25:4 (2005), 823–829.
16. Bellinger, D.C., Inorganic arsenic exposure and children's neurodevelopment: a review of the evidence. Toxics 1:1 (2013), 2–17.
17. Bhattacharyya, M.H., Bioavailability of orally administered cadmium and lead to the mother, fetus, and neonate during pregnancy and lactation: an overview. Sci. Total Environ. 28:1–3 (1983), 327–342.
18. Bhowmik, A., Khan, R., Ghosh, M.K., Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed. Res. Int. 2015 (2015), 1–20.
19. Bjornberg, K.A., Vahter, M., Petersson-Grawé, K., Glynn, A., Cnattingius, S., Darnerud, P.O., Atuma, S., Aune, M., Becker, W., Berglund, M., Methyl mercury and inorganic mercury in swedish pregnant women and in cord blood: influence of fish consumption. Environ. Health Perspect. 111:4 (2003), 637–641.
20. Borgert, C.J., Predicting interactions from mechanistic information: can omic data validate theories?. Toxicol. Appl. Pharmacol. 223:2 (2007), 114–120.
21. Bradbury, M.W., Deane, R., Permeability of the blood brain barrier to lead. Neurotoxicology 14:2-3 (1993), 131–136.
22. Bridges, C.C., Zalups, R.K., Molecular and ionic mimicry and the transport of toxic metals. Toxicol. Appl. Pharmacol. 204:3 (2005), 274–308.
23. Brookes, N., Kristt, D.A., Inhibition of amino acid transport and protein synthesis by HgCl2 and methylmercury in astrocytes: selectivity and reversibility. J. Neurochem. 53:4 (1989), 1228–1237.
24. Brookes, N., In vitro evidence for the role of glutamate in the CNS toxicity of mercury. Toxicology 76:3 (1992), 245–256.
25. Centers for Disease Control and Prevention (CDC), Fourth national report on human exposure to environmental chemicals 1-108., 2014 Available online: https://www.cdc.gov/exposurereport/.
26. Caldwell, D.J., Mastrocco, F., Margiotta-Casaluci, L., Brooks, B.W., An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research. Chemosphere 115:1 (2014), 4–12.
27. Carrier, G., Bouchard, M., Brunet, R.C., Caza, M., A Toxicokinetic model for predicting the tissue distribution and elimination of organic and inorganic mercury following exposure to methyl Mercury in animals and humans. II. Application and validation of the model in humans. Toxicol. Appl. Pharmacol. 171:1 (2001), 50–60.
28. Caserta, D., Graziano, A., Monte, G., Lo Bordi, G., Moscarini, M., Heavy metals and placental fetal maternal barrier: a mini review on the major concerns. Eur. Rev. Med. Pharmacol. Sci. 17:16 (2013), 2198–2206.
29. Castoldi, A.F., Coccini, T., Manzo, L., Neurotoxic and molecular effects of methylmercury in humans. Rev. Environ. Health 18:1 (2003), 19–31.
30. Ceccatelli, S., Daré, E., Moors, M., Methylmercury induced neurotoxicity and apoptosis. Chem. Biol. Interact. 188:2 (2010), 301–308.
31. Cecil, K.M., Brubaker, C.J., Adler, C.M., Dietrich, K.N., Altaye, M., Egelhoff, J.C., Wessel, S., Elangovan, I., Hornung, R., Jarvis, K., Lanphear, B.P., Decreased brain volume in adults with childhood lead exposure. PLoS Med. 5:5 (2008), 741–750.
32. Cedergreen, N., Quantifying synergy: a systematic review of mixture toxicity studies within environmental toxicology. PLoS One, 9(5), 2014 e96580–e96580.
33. Chandra, V., Gestational cadmium exposure development: a biochemical study. Ind. Health 29:2 (1991), 65–71.
34. Choi, B.H., The effects of methyl mercury on the developing brain. Prog. Neurobiol. 32:6 (1989), 447–470.
35. Choi, D.W., Excitotoxic cell death. J. Neurobiol. 23:9 (1992), 1261–1276.
36. Clarkson, T.W., Magos, L., The toxicology of mercury and its chemical compounds. Crit. Rev. Toxicol. 36:8 (2006), 609–662.
37. Clarkson, T.W., Magos, L., Myers, G.J., The toxicology of mercury current exposures and clinical manifestations. N. Engl. J. M. Med. 349 (2003), 1731–1737.
38. Clarkson, T.W., Metal toxicity in the central nervous system. Environ. Health Perspect. 75:15 (1987), 59–64.
39. Crespo-Lopez, M.E., Macedo, G.L., Pereira, S.I.D., Arrifano, G.P.F., Picanço-Diniz, D.L.W., Nascimento, J.L.M., Do Herculano, A.M., Mercury and human genotoxicity: critical considerations and possible molecular mechanisms. Pharmacol. Res. 60:4 (2009), 212–220.
40. Cronican, A.A., Fitz, N.F., Carter, A., Saleem, M., Shiva, S., Barchowsky, A., Koldamova, R., Schug, J., Lefterov, I., Genome wide alteration of histone H3K9 acetylation pattern in mouse offspring prenatally exposed to arsenic. PLoS One, 8(2), 2013, e53478.
41. Czarnecki, L.A., Moberly, A.H., Turkel, D.J., Rubinstein, T., Pottackal, J., Rosenthal, M.C., McCandlish, E.F.K., Buckley, B., McGann, J.P., Functional rehabilitation of cadmium induced neurotoxicity despite persistent peripheral pathophysiology in the olfactory System. Toxicol. Sci. 126:2 (2012), 534–544.
42. Dave, V., Mullaney, K.J., Goderie, S., Kimelberg, H.K., Aschner, M., Astrocytes as mediators of methylmercury neurotoxicity: effects on D-aspartate and serotonin uptake. Dev. Neurosci. 16:3–4 (1994), 222–231.
43. Debes, F., Budtz-Jorgensen, E., Weihe, P., White, R.F., Grandjean, P., Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol. Teratol. 28:5 (2006), 536–547.
44. Duffus, J.H., Heavy metals-a meaningless term?. Pure Appl. Chem. 74:5 (2002), 793–807.
45. Durczok, A., Szkilnik, R., Nowak, P., Labus Dabrowska, J., Bortel, A., Zagził, T., Swoboda, M., Rycerski, W., Winnicka, H., Kostrzewa, R.M., Kwieciński, A., Brus, R., The effects of zinc on the central dopaminergic system of rats prenatally exposed to cadmium. Pol. J. Environ. Stud. 14:5 (2005), 569–576.
46. El-Masri, H.A., Experimental and mathematical modeling methods for the investigation of toxicological interactions. Toxicol. Appl. Pharmacol. 223:2 (2007), 148–154.
47. Esteban-Vasallo, M.D., Aragones, N., Pollan, M., Lopez-Abente, G., Perez-Gomez, B., Mercury, cadmium, and lead levels in human placenta: a systematic review. Environ. Health Perspect. 120:10 (2012), 1369–1377.
48. Farina, M., Franco, J.L., Ribas, C.M., Meotti, F.C., Missau, F.C., Pizzolatti, M.G., Dafre, A.L., Santos, A.R.S., Protective effects of polygala paniculata extract against methylmercury induced neurotoxicity in mice. J. Pharm. Pharmacol. 57:11 (2005), 1503–1508.
49. Farina, M., Rocha, J.B.T., Aschner, M., Mechanisms of methylmercury induced neurotoxicity: evidence from experimental studies. Life Sci. 89:15–16 (2011), 555–563.
50. Felix, K., Manna, S.K., Wise, K., Barr, J., Ramesh, G.T., Low levels of arsenite activates nuclear factor kappaB and activator protein-1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol. 19:2 (2005), 67–77.
51. Franco, J.L., Braga, H.C., Stringari, J., Missau, F.C., Posser, T., Mendes, B.G., Leal, R.B., Santos, A.R.S., Dafre, A.L., Pizzolatti, M.G., Farina, M., Mercurial induced hydrogen peroxide generation in mouse brain mitochondria: protective effects of quercetin. Chem. Res. Toxicol. 20:12 (2007), 1919–1926.
52. +2 interaction with NMDA receptor channels. Neurochem. Int. 52:1–2 (2008), 329–337.
53. Giasson, B.I., Sampathu, D.M., Wilson, C.A., Vogelsberg-Ragaglia, V., Mushynski, W.E., Lee, V.M.Y., The environmental toxin arsenite induces tau hyperphosphorylation. Biochemistry 41:51 (2002), 15376–15387.
54. Gong, G., O'Bryan, S.E., The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 24:4 (2010), 311–316.
55. Goyer, R.A., Results of lead research: prenatal exposure and neurological consequences. Environ. Health Perspect. 104:10 (1996), 1050–1054.
56. Goyer, R.A., Toxic and essential metal interactions. Annu. Rev. Nutr. 17 (1997), 37–50.
57. Grandjean, P., Jorgensen, P.J., Weihe, P., Human milk as a source of methylmercury exposure in infants. Environ. Health Perspect. 102:1 (1994), 74–77.
58. Guilarte, T.R., Miceli, R.C., Age dependent effects of lead on [3H]MK-801 binding to the NMDA receptor gated ionophore: in vitro and in vivo studies. Neurosci. Lett. 148:1–2 (1992), 27–30.
59. +2. Mol. Brain. Res. 76:2 (2000), 299–305.
60. Gundacker, C., Hengstschlager, M., The role of the placenta in fetal exposure to heavy metals. Wien. Med. Wochenschr. 162:9–10 (2012), 201–206.
61. Hart, R.P., Rose, C.S., Hamer, R.M., Neuropsychological effects of occupational exposure to cadmium. J. Clin. Exp. Neuropsychol. 11:6 (1989), 933–943.
62. Hayat, S., Wigley, C.B., Robbins, J., Intracellular calcium handling in rat olfactory ensheathing cells and its role in axonal regeneration. Mol. Cell. Neurosci. 22:2 (2003), 259–270.
63. He, Z.L., Yang, X.E., Stoffella, P.J., Trace elements in agroecosystems and impacts on the environment. J. Trace Elem. Med. Biol. 19:2–3 (2005), 125–140.
64. Huguenard, J.R., Lowthreshold calcium currents in central nervous system neurons. Annu. Rev. Physiol 58 (1996), 329–348.
65. Jarup, L., Hazards of heavy metal contamination. Br. Med. Bull. 68:1 (2003), 167–182.
66. Jett, D.A., Kuhlmann, A.C., Farmer, S.J., Guilarte, T.R., Age dependent effects of developmental lead exposure on performance in the morris water maze. Pharmacol. Biochem. Behav. 57:1–2 (1997), 271–279.
67. Patocka, Jiri, Neurotoxicity of heavy metals in the light of gender studies. J. Nurs. Soc. Stud. Pub. Health Rehabil. 1 (2014), 270–282.
68. Johansson, C., Castoldi, A.F., Onishchenko, N., Manzo, L., Vahter, M., Ceccatelli, S., Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox. Res. 11:3–4 (2007), 241–260.
69. Joseph, B., Sandra, C., Varvara, G., Maurice, W., Andrew, W., EURL ECVAM strategy for achieving 3Rs impact in the assessment of toxicokinetics and systemic toxicity., 2015 Available online: https://ec.europa.eu/jrc/en/publication/eur-scientific-and-technical-research-reports.
70. Jusko, T.A., Henderson, C.R., Lanphear, B.P., CorSlechta, D.A., Parsons, P.J., Canfield, R.L., Blood lead concentrations <10 μg/dL and child intelligence at 6 years of age. Environ. Health Perspect. 116:2 (2008), 243–248.
71. Kim, M.J., Dunah, A.W., Wang, Y.T., Sheng, M., Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46:5 (2005), 745–760.
72. Kruger, K., Binding, N., Straub, H., Mußhoff, U., Effects of arsenite on long term potentiation in hippocampal slices from young and adult rats. Toxicol. Lett. 165:2 (2006), 167–173.
73. Kruger, K., Straub, H., Hirner, A.V., Hippler, J., Binding, N., Musshoff, U., Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats. Toxicol. Appl. Pharmacol. 236:1 (2009), 115–123.
74. Kuhlmann, A.C., McGlothan, J.L., Guilarte, T.R., Developmental lead exposure causes spatial learning deficits in adult rats. Neurosci. Lett. 233:1–2 (1997), 101–104.
75. Kumar, R., Agarwal, A.K., Seth, P.K., Oxidative stress-mediated neurotoxicity of cadmium. Toxicol. Lett. 89:1 (1996), 65–69.
76. Kumar, P., Sannadi, S., Reddy, R., 2013. Alterations in apoptotic caspases and antioxidant enzymes in arsenic exposed rat brain regions: Reversal effect of essential metals and a chelating agent 6(3), 1150–1166.
77. Lafon Cazal, M., Pietri, S., Culcasi, M., Bockaert, J., NMDA dependent superoxide production and neurotoxicity. Nature 364:3 (1993), 535–537.
78. Lai, B.C.L., Marion, S.A., Teschke, K., Tsui, J.K.C., Occupational and environmental risk factors for Parkinson's disease. Parkinsonism Relat. Disord. 8:5 (2002), 297–309.
79. Landrigan, P.J., Pediatric lead poisoning: is there a threshold. Public Health Rep. 115:6 (2000), 530–531.
80. Lasley, S.M., Green, M.C., Gilbert, M.E., Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicol. Teratol. 23:2 (2001), 185–189.
81. LeBel, C.P., Ali, S.F., McKee, M., Bondy, S.C., Organometal induced increases in oxygen reactive species: the potential of 2', 7'-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 104:1 (1990), 17–24.
82. Leong, C.C., Syed, N.I., Lorscheider, F.L., Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 12:4 (2001), 733–737.
83. Li, R., Huang, F.S., Abbas, A.K., Wigstrom, H., Role of NMDA receptor subtypes in different forms of NMDA dependent synaptic plasticity. BMC Neurosci., 8, 2007, 55.
84. Lin, C.M., Doyle, P., Wang, D., Hwang, Y.H., Chen, P.C., Does prenatal cadmium exposure affect fetal and child growth. Occup. Environ. Med. 68:9 (2011), 641–646.
85. Lopez, E., Arce, C., Oset-Gasque, M.J., Canadas, S., Gonzalez, M.P., Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic. Biol. Med. 40:6 (2006), 940–951.
86. Luo, J., Qiu, Z., Shu, W., Zhang, Y., Zhang, L., Chen, J., Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol. Lett. 184:2 (2009), 121–125.
87. Manton, W.I., Kirkpatrick, J.B., Cook, J.D., Does the choroid plexus really protect the brain from lead?. Lancet, 2(8398), 1984, 351.
88. Mari, M., Nadal, M., Schuhmacher, M., Barberia, E., Garcia, F., Domingo, J.L., Human exposure to metals: levels in autopsy tissues of individuals living near a hazardous waste incinerator. Biol. Trace Elem. Res. 159:1–3 (2014), 15–21.
89. Martinez-Finley, E.J., Goggin, S.L., Labrecque, M.T., Allan, A.M., Reduced expression of MAPK/ERK genes in perinatal arsenic exposed offspring induced by glucocorticoid receptor deficits. Neurotoxicol. Teratol. 33:5 (2011), 530–537.
90. McCall, M.A., Gregg, R.G., Behringer, R.R., Brenner, M., Delaney, C.L., Galbreath, E.J., Zhang, C.L., Pearce, R.A., Chiu, S.Y., Messing, A., Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 6361–6366.
91. Mejía, J.J., Díaz-Barriga, F., Calderon, J., Rios, C., Jimenez-Capdeville, M.E., Effects of lead arsenic combined exposure on central monoaminergic systems. Neurotoxicol. Teratol. 19:6 (1997), 489–497.
92. Mendez-Armenta, M., Rios, C., Cadmium neurotoxicity. Environ. Toxicol. Pharmacol. 23:3 (2007), 350–358.
93. Minami, A., Takeda, A., Nishibaba, D., Takefuta, S., Oku, N., Cadmium toxicity in synaptic neurotransmission in the brain. Brain Res. 894:2 (2001), 336–339.
94. Mori, N., Yasutake, A., Hirayama, K., Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Arch. Toxicol. 81:11 (2007), 769–776.
95. Moss, D.W., Bates, T.E., Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur. J. Neurosci. 13:3 (2001), 529–538.
96. Nadal, M., Schuhmacher, M., Domingo, J.L., Metal pollution of soils and vegetation in an area with petrochemical industry. Sci. Total Environ. 321:1–3 (2004), 59–69.
97. Namgung, U., Xia, Z., Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol. Appl. Pharmacol. 174:2 (2001), 130–138.
98. Naujokas, M.F., Anderson, B., Ahsan, H., Aposhian, H.V., Graziano, J.H., Thompson, C., Suk, W.A., The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ. Health Perspect. 121:3 (2013), 295–302.
99. Neal, A.P., Worley, P.F., Guilarte, T.R., Lead exposure during synaptogenesis alters NMDA receptor targeting via NMDA receptor inhibition. Neurotoxicology 32:2 (2011), 281–289.
100. O'Flaherty, E.J., Physiologically based models for bone seeking elements. III. Human skeletal and bone growth. Toxicol. Appl. Pharmacol. 111:2 (1991), 332–341.
101. O'Flaherty, E.J., Physiologically based models of metal kinetics. Crit. Rev. Toxicol. 28:3 (1998), 71–317.
102. Orrenius, S., Nicotera, P., The calcium ion and cell death. J. Neural Transm. Suppl. 43 (1994), 1–11.
103. +-ATPase and acetylcholinesterase) in various regions of adult rat brain. Neurochem. Int. 23:5 (1993), 451–458.
104. Patlolla, A.K., Tchounwou, P.B., Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague dawley rats. Int. J. Environ. Res. Public Health 2:1 (2005), 80–83.
105. Piloni, N.E., Fermandez, V., Videla, L.A., Puntarulo, S., Acute iron overload and oxidative stress in brain. Toxicology 314:1 (2013), 174–182.
106. Prakash, C., Soni, M., Kumar, V., Mitochondrial oxidative stress and dysfunction in arsenic neurotoxicity: a review. J. Appl. Toxicol 36:2 (2015), 179–188.
107. Rai, A., Maurya, S.K., Khare, P., Srivastava, A., Bandyopadhyay, S., Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions. Toxicol. Sci. 118:2 (2010), 586–601.
108. Rao, M.V., Avani, G., Arsenic induced free radical toxicity in brain of mice. Indian J. Exp. Biol. 42:5 (2004), 495–498.
109. Rigon, A.P., Cordova, F.M., Oliveira, C.S., Posser, T., Costa, A.P., Silva, I.G., Santos, D.A., Rossi, F.M., Rocha, J.B.T., Leal, R.B., Neurotoxicity of cadmium on immature hippocampus and a neuroprotective role for p38MAPK. Neurotoxicology 29:4 (2008), 727–734.
110. Rodríguez, V.M., Dufour, L., Carrizales, L., Díaz-Barriga, F., Jiménez-Capdeville, M.E., Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environ. Health Perspect. 106:8 (1998), 487–491.
111. Rodriguez, V.M., Carrizales, L., Mendoza, M.S., Fajardo, O.R., Giordano, M., Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol. Teratol. 24:6 (2002), 743–750.
112. Rovira, J., Nadal, M., Schuhmacher, M., Domingo, J.L., Human exposure to trace elements through the skin by direct contact with clothing. Risk Assess. Environ. Res. 140 (2015), 308–316.
113. Ruff, H.A., Markowitz, M.E., Bijur, P.E., Rosen, J.F., Relationships among blood lead levels, iron deficiency, and cognitive development in two year old children. Environ. Health Perspect. 104:2 (1996), 180–185.
114. Sadiq, S., Ghazala, Z., Chowdhury, A., Busselberg, D., Metal toxicity at the synapse: presynaptic, postsynaptic, and longterm effects. J. Toxicol., 2012, 2012.
115. Sanders, T., Liu, Y., Buchner, V., Tchounwou, P.B., Neurotoxic effects and biomarkers of lead exposure: a review. Rev. Environ. Health 24:1 (2009), 15–45.
116. +2and inositol phosphate levels in cultured cerebellar granule neurons. J. Neurochem. 61:2 (1993), 648–657.
117. Sasso, A.F., Isukapalli, S.S., Georgopoulos, P.G., A generalized physiologically-based toxicokinetic modeling system for chemical mixtures containing metals. Theor. Biol. Med. Modell. 7 (2010), 1–17.
118. Saunders, N.R., Dreifuss, J.J., Dziegielewska, K.M., Johansson, P.A., Habgood, M.D., Mollgard, K., Bauer, H.C., The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history. Front. Neurosci. 8 (2014), 1–26.
119. Sharma, R.P., Schuhmacher, M., Kumar, V., Review on crosstalk and common mechanisms of endocrine disruptors: scaffolding to improve PBPK/PD model of EDCs mixture. Environmental International, 2016 in press.
120. Shukla, G.S., Chandra, S.V., Concurrent exposure to lead, manganese, and cadmium and their distribution to various brain regions, liver, kidney, and testis of growing rats. Arch. Environ. Contam. Toxicol. 16:3 (1987), 303–310.
121. Slomianka, L., Rungby, J., West, M.J., Danscher, G., Andersen, A.H., Dose-dependent bimodal effect of low level lead exposure on the developing hippocampal region of the rat: a volumetric study. Neurotoxicology 10:2 (1989), 177–190.
122. Snyder, J.S., Hong, N.S., McDonald, R.J., Wojtowicz, J.M., A role for adult neurogenesis in spatial long term memory. Neuroscience 130:4 (2005), 843–852.
123. Stackelberg, K.V., Elizabeth, G., Tian, C., Birgit, C.H., Mixtures, metals, genes and pathways: A systematic review methods for research synthesis. 2013 Available online: https://cdn1.sph.harvard.edu.
124. Suzuki, T., Shishido, S., Ishihara, N., Different behaviour of inorganic and organic mercury in renal excretion with reference to effects of D-penicillamine. Br. J. Ind. Med. 33:2 (1976), 88–91.
125. Tan, Y.M., Clewell, H., Campbell, J., Andersen, M., Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment. Int. J. Environ. Res. Public Health 8:5 (2011), 1613–1630.
126. Tolins, M., Ruchirawat, M., Landrigan, P., The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure. Ann. Glob. Health 80:4 (2014), 303–314.
127. Toscano, C.D., Guilarte, T.R., Lead neurotoxicity: from exposure to molecular effects. Brain Res. Rev. 49:3 (2005), 529–554.
128. Tyler, C.R., Allan, A.M., The Effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Curr. Environ. Health Rep. 1:2 (2014), 132–147.
129. Uchida, Y., Takio, K., Titani, K., Ihara, Y., Tomonaga, M., The growth inhibitory factor that is deficient in the alzheimer's disease brain is a 68 amino acid metallothionein like protein. Neuron 7:2 (1991), 337–347.
130. Vahter, M., Effects of arsenic on maternal and fetal health. Annu. Rev. Nutr. 29 (2009), 381–399.
131. Viaene, M.K., Masschelein, R., Leenders, J., De Groof, M., Swerts, L.J., Roels, H.A., Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study. Occup. Environ. Med. 57:1 (2000), 19–27.
132. Vilavert, L., Nadal, M., Schuhmacher, M., Domingo, J.L., Two decades of environmental surveillance in the vicinity of a waste incinerator: human health risks associated with metals and PCDD/Fs. Arch. Environ. Contam. Toxicol. 69:2 (2015), 241–253.
133. World Health Organization (WHO), 2007. Health risks of heavy metals from long range trans boundary air polution. Jt. WHO l Conv. Task Force Heal. Asp. Air Pollut. 2–144.
134. World Health Organization (WHO), 2010. WHO | Ten chemicals of major public health concern.
135. Wang, B., Du, Y., Cadmium and its neurotoxic effects. Oxid. Med. Cell. Longev., 2013, 2013.
136. Wang, G., Fowler, B.A., Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol. Appl. Pharmacol. 233:1 (2008), 92–99.
137. Wasserman, G.A., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., van Geen, A., Slavkovich, V., Lolacono, N.J., Cheng, Z., Hussain, I., Momotaj, H., Graziano, J.H., Water arsenic exposure and children's intellectual function in araihazar, bangladesh. Environ. Health Perspect. 112:13 (2004), 1329–1333.
138. Wong, K.L., Klaassen, C.D., Neurotoxic effects of cadmium in young rats. Toxicol. Appl. Pharmacol. 63:3 (1982), 330–337.
139. Wright, R.O., Baccarelli, A., Metals and neurotoxicology. J. Nutr. 137:12 (2007), 2809–2813.
140. Xi, S., Guo, L., Qi, R., Sun, W., Jin, Y., Sun, G., Prenatal and early life arsenic exposure induced oxidative damage and altered activities and mRNA expressions of neurotransmitter metabolic enzymes in offspring rat brain. J. Biochem. Mol. Toxicol. 24:6 (2010), 368–378.
141. Xu, B., Chen, S., Luo, Y., Chen, Z., Liu, L., Zhou, H., Chen, W., Shen, T., Han, X., Chen, L., Calcium signaling is involved in cadmium induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network. PLoS One, 6(4), 2011, e19052.
142. Yadav, R.S., Shukla, R.K., Sankhwar, M.L., Patel, D.K., Ansari, R.W., Pant, A.B., Islam, F., Khanna, V.K., Neuroprotective effect of curcumin in arsenic induced neurotoxicity in rats. Neurotoxicology 31:5 (2010), 533–539.
143. Yin, J.C., Wallach, J.S., Del Vecchio, M., Wilder, E.L., Zhou, H., Quinn, W.G., Tully, T., Induction of a dominant negative CREB transgene specifically blocks longterm memory in drosophila. Cell 79:1 (1994), 49–58.
144. Yin, J.C., Del Vecchio, M., Zhou, H., Tully, T., CREB as a memory modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in Drosophila. Cell 81:1 (1995), 107–115.
145. Yokel, R.A., Blood brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal induced neurodegeneration. J. Alzheimers Dis. 10:2–3 (2006), 223–253.
146. Yu, X.D., Yan, C.H., Shen, X.M., Tian, Y., Cao, L.L., Yu, X.G., Zhao, L., Liu, J.X., Prenatal exposure to multiple toxic heavy metals and neonatal neurobehavioral development in Shanghai, China. Neurotoxicol. Teratol. 33:4 (2011), 437–443.
147. Yu, D., A physiologically based pharmacokinetic model of inorganic arsenic. Regul. Toxicol. Pharmacol. 29:2 (1999), 128–141.
148. Zhang, X., Liu, A.-P., Ruan, D.-Y., Liu, J., Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin labeled in situ hybridization histochemistry. Neurotoxicol. Teratol. 24:2 (2002), 149–160.
149. Zheng, W., Aschner, M., Ghersi-Egea, J.F., Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol. Appl. Pharmacol. 192:1 (2003), 1–11.
150. Zheng, W., Toxicology of choroid plexus: special reference to metal- induced neurotoxicities. Microsc. Res. Tech. 52:1 (2001), 89–103.
151. Zhu, H., Jia, Y., Cao, H., Meng, F., Liu, X., Biochemical and histopathological effects of subchronic oral exposure of rats to a mixture of five toxic elements. Food Chem. Toxicol. 71 (2014), 166–175.